NCT05724212View on ClinicalTrials.gov

Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment

Active, not recruitingOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

January 27, 2017

Primary Completion Date

May 13, 2021

Study Completion Date

February 1, 2025

Conditions
Tuberculosis
Interventions
DIAGNOSTIC_TEST

Interferon gamma release assay (IGRA)

in vitro test

Trial Locations (1)

20132

IRCCS San Raffaele Scientific Institute, Milan

All Listed Sponsors
lead

Paola Mantegani

OTHER

NCT05724212 - Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment | Biotech Hunter | Biotech Hunter